article thumbnail

Daewoong Pharmaceutical revolutionizes drug development with AI-Driven DAISY system

Digital Health Global

Daewoong Pharmaceutical , a prominent player in the South Korean pharmaceutical industry, has unveiled its groundbreaking drug development system, Daewoong AI System (DAISY). About DAISY DAISY represents the culmination of over 40 years of research and development by Daewoong Pharmaceutical.

article thumbnail

The next revolution in the pharmaceutical industry: the transformative potential of AI

Digital Health Global

The pharmaceutical landscape is undergoing a momentous transformation, marked by the convergence of cutting-edge technologies that are redefining every aspect of the industry. The first application of AI to the pharmaceutical industry is its use in ramping up and improving new drug discovery.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

Drug population and drug protocol fit account for nearly 75% of these failures. By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drug development. Petra Jantzer, Ph.D., Petra Jantzer, Ph.D.,

article thumbnail

Drug Discovery and Early Development Outsourcing Services Industry Analysis – M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion – ResearchAndMarkets.com

Digital Health Global

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity.

article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

By the power vested in clinical research, the FDA now pronounces us patient and industry. The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. I’m here to deliver some great news: we tied the knot!

BioTech 144
article thumbnail

The Impact of Agile In The Pharmaceutical Industry

Electronic Health Reporter

As many know, the pharmaceutical industry is heavily regulated and specialized, with slow drug-development timelines, strict processes and quality requirements, and rigid silos. The article The Impact of Agile In The Pharmaceutical Industry appeared first on electronichealthreporter.com.

article thumbnail

How AI is Shaping Drug Discovery at AION Labs

Healthcare IT Today

Mati Gil, CEO at AION Labs , stands at the forefront of this revolution, pioneering the use of AI to tackle the challenges inherent in the pharma industry. In a recent video interview below, he shared insights into how AI is transforming drug discovery, emphasizing the need for innovation in an industry marked by complexity and high stakes.